Bioprocess and manufacturing at World Vaccine Congress Europe 2026
Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website
61 organizations at World Vaccine Congress Europe 2026 present work in bioprocess & manufacturing: 44 suppliers and service providers, 8 vaccine and drug developers, 7 public-health and non-profit bodies and 2 academic bodies. Between them they bring 70 presentations to the program. Most represented: GSK (7 on the program), IAVI (6 on the program), European Commission (5 on the program). 55 of them have their own page in this guide. As of Sep 26, 2026.
All 251 organizations at World Vaccine Congress Europe 2026 →
Format
Top represented
Showing 1–11 of 61 organizations
| Organization | World Vaccine Congress Europe 2026 Attendance |
|---|---|
GSK London, United Kingdom | |
Panel Mon Oct 19 12:15 Talk Mon Oct 19 15:00 Panel: Global Vaccine Access: Balancing Speed and Safety How regulators worldwide can speed vaccine approval, for example by relying on other agencies' reviews, without weakening safety checks. Panel Wed Oct 21 10:45 Panel: Emerging Outbreaks at the Front Line: From Early Signals to Real-World Response How outbreaks like bird flu and hantavirus can be spotted sooner, what vaccines add to the response, and where gaps remain. Talk Wed Oct 21 13:15 Panel Wed Oct 21 14:30 Panel: Can TB vaccines deliver on the promise? What tuberculosis vaccine trials can learn from COVID-19, flu and respiratory syncytial virus, and how to make tuberculosis a funding priority. Talk Wed Oct 21 15:00 Panel: Designing Better Vaccine Trials: The Role and Reality of Modelling Whether models built from manufacturing and early trial data can shrink vaccine trials, and what evidence regulators need to trust them. | |
IAVI New York, NY | |
Non-profit research organization developing vaccines and antibodies for HIV, tuberculosis and emerging infectious diseases. | Talk Mon Oct 19 11:30 Talk Mon Oct 19 11:45 Panel Mon Oct 19 12:15 Talk Wed Oct 21 10:30 Panel Wed Oct 21 13:15 Panel: Rethinking AMR Priorities: Choosing the Targets That Move the Needle How to choose which drug-resistant bacteria to target with vaccines and antibody drugs, using cost-effectiveness models to line up funders and drugmakers. Panel Wed Oct 21 14:30 Panel: Can TB vaccines deliver on the promise? What tuberculosis vaccine trials can learn from COVID-19, flu and respiratory syncytial virus, and how to make tuberculosis a funding priority. |
European Commission Brussels, Belgium | |
Executive body of the European Union, setting EU health, health-security and veterinary policy. | Panel Tue Oct 20 17:10 One Health in Action: Connecting Human, Animal, and Environmental Health to Advance Vaccine Strategy How tracking disease in people, animals and the environment together can set vaccine priorities for infections that jump from animals, like bird flu. One Health & ecosystems Talk Wed Oct 21 09:00 The New Geopolitics of Vaccines: Global Vaccine Manufacturing in a Fractured World How governments and industry can keep vaccines flowing fairly across borders in an emergency as countries push to make vaccines at home. Supply, safety & accessBioprocess & manufacturing Talk Wed Oct 21 10:45 Panel Wed Oct 21 11:00 Panel: Rethinking Livestock Vaccination for Emerging Threats How to speed new livestock vaccines against diseases that can jump to people, weighing approval rules, food safety, trade and funding incentives. Talk Wed Oct 21 12:15 Panel: The New Geography of Vaccine Innovation: Why the Next Decade of Vaccine Development Will Be Driven by LMICs Why low- and middle-income countries are becoming vaccine innovators, not just trial sites, and what funding and regional regulatory cooperation they need. Panel Wed Oct 21 16:00 Europe’s Vision for Global Health Security: Designing Sustainable Vaccine Financing and Preparedness Systems How Europe can shift vaccine funding from crisis-driven spending to long-term plans, using tools like joint purchasing and advance promises to buy. Supply, safety & access |
CEPI Oslo, Norway | |
Coalition for Epidemic Preparedness Innovations: global partnership funding vaccines against emerging infectious diseases and epidemic threats. | Panel Mon Oct 19 12:15 Talk Tue Oct 20 16:00 Panel: Expanding the Access & Impact of Adjuvants How to get past licensing and approval hurdles so new adjuvants, ingredients that boost a vaccine's immune response, reach more countries. Panel Wed Oct 21 13:30 Panel: Controlled Human Infection Models (CHIMs): Evidence, Ethics and the Next Phase of Vaccine R&D How studies that deliberately infect volunteers guide vaccine decisions, and what must be in place before using them for new diseases. Panel Wed Oct 21 16:00 Europe’s Vision for Global Health Security: Designing Sustainable Vaccine Financing and Preparedness Systems How Europe can shift vaccine funding from crisis-driven spending to long-term plans, using tools like joint purchasing and advance promises to buy. Supply, safety & access |
Johnson & Johnson New Brunswick, NJ | |
Talk Tue Oct 20 14:00 Talk Tue Oct 20 16:00 | |
Develops mucosal vaccines against serious infectious diseases on a proprietary platform of outer membrane vesicles (OMVs). | Booth Exhibiting (no floor booth listed) Talk Mon Oct 19 10:30 Talk Wed Oct 21 10:30 From Innovation to Impact: Translating OMV Vaccine Technology into Clinical Reality How a developer and a contract manufacturer take vaccines made from outer membrane vesicles, tiny bacterial bubbles, from research toward clinical trials. |
Inimmune Missoula, MT | |
Biotech designing and developing TLR agonist adjuvants and immunotherapeutics. | Talk Mon Oct 19 14:00 Talk Wed Oct 21 10:45 |
Swiss centre of expertise in adjuvants and vaccine formulation that develops adjuvants and supplies them at GMP grade under open-access terms. | Booth Exhibiting at Booth 537 Talk Tue Oct 20 16:00 Panel: Expanding the Access & Impact of Adjuvants How to get past licensing and approval hurdles so new adjuvants, ingredients that boost a vaccine's immune response, reach more countries. |
Africa CDC Addis Ababa, Ethiopia | |
The African Union's public health agency, supporting disease surveillance, outbreak response and local vaccine manufacturing across Africa. | Talk Wed Oct 21 09:00 The New Geopolitics of Vaccines: Global Vaccine Manufacturing in a Fractured World How governments and industry can keep vaccines flowing fairly across borders in an emergency as countries push to make vaccines at home. Supply, safety & accessBioprocess & manufacturing |
UNICEF New York, NY | |
UN children's agency and one of the largest vaccine buyers, procuring and supplying vaccines for low- and middle-income countries. | Talk Wed Oct 21 09:00 The New Geopolitics of Vaccines: Global Vaccine Manufacturing in a Fractured World How governments and industry can keep vaccines flowing fairly across borders in an emergency as countries push to make vaccines at home. Supply, safety & accessBioprocess & manufacturing |
HL Hilleman Laboratories Singapore, Singapore | |
Vaccine research and development organization, founded by MSD and Wellcome, developing affordable vaccines for low- and middle-income countries. | Booth Exhibiting (no floor booth listed) Talk Tue Oct 20 11:30 Working Group: Forging Outbreak-ready Vaccine Partnerships Infectious disease & AMRSupply, safety & access Talk Wed Oct 21 09:00 The New Geopolitics of Vaccines: Global Vaccine Manufacturing in a Fractured World How governments and industry can keep vaccines flowing fairly across borders in an emergency as countries push to make vaccines at home. Supply, safety & accessBioprocess & manufacturing Talk Wed Oct 21 12:15 Panel: The New Geography of Vaccine Innovation: Why the Next Decade of Vaccine Development Will Be Driven by LMICs Why low- and middle-income countries are becoming vaccine innovators, not just trial sites, and what funding and regional regulatory cooperation they need. |
Instantly find 20 buyers in bioprocess & manufacturing
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse World Vaccine Congress Europe 2026 by
Organization type
Topic
Exhibit hall
Everyone
Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction